Luke L. Lairson - Concepedia

Author

Luke L. Lairson

Also Known As

L. L. Lairson, L. Lairson, L.L. Lairson, Lairson, Luke L., Lairson, Luke Lee, Luke L. Lairson, Luke L Lairson, Luke L. Lairson, Luke Lairson, Stefano Forli

111

Publications

7.5K

Citations

H-Index

112

Concepts

All Affiliations

Scripps Research Institute California Institute for Biomedical Research University of British Columbia Genomics Institute of the Novartis Research Foundation Cornell University

About

Luke L. Lairson is an author at Scripps Research Institute specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	24	3.2K
2	Biochemistry	14	14	1.7K
3	Natural Sciences	9	9	853
4	Engineering	5	5	630
5	Social Sciences	1	1	117

Luke L. Lairson

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
A regenerative approach to the treatment of multiple sclerosis V. Deshmukh, Virginie Tardif, Costas A. Lyssiotis, Nature Regenerative MedicineNeuroregenerationNeurological DisorderMedicineRehabilitation	2013	508
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic Emily N. Chin, Chenguang Yu, Vincent F. Vartabedian, Science	2020	483
Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4 Costas A. Lyssiotis, Ruth K. Foreman, Judith Staerk, Proceedings of the National Academy of Sciences Regenerative MedicineSmall-molecule Screening PlatformInduced Pluripotent Stem CellDevelopmental BiologyPluripotent Stem Cells	2009	363
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells Ekaterina V. Vinogradova, Xiaoyu Zhang, David Remillard, Cell Electrophile-cysteine InteractionsSignal TransductionBiochemistryCell InteractionCell Trafficking	2020	352
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers Edouard Mullarky, Natasha C. Lucki, Reza Beheshti Zavareh, Proceedings of the National Academy of Sciences EngineeringAldo-keto ReductaseSmall Molecule InhibitorSerine BiosynthesisCancer Biology	2016	331
A metabolite-derived protein modification integrates glycolysis with KEAP1–NRF2 signalling Michael J. Bollong, Gihoon Lee, John S. Coukos, Nature BiochemistryMedicineNatural SciencesMetabolic RegulationMetabolism	2018	330
High-throughput screening methodology for the directed evolution of glycosyltransferases Amir Aharoni, K. Thieme, Cecilia Chiu, Nature Methods BiosynthesisEngineeringBiotransformationDirected EvolutionGlycobiology	2006	235
Structural analysis of the sialyltransferase CstII from Campylobacter jejuni in complex with a substrate analog Cecilia Chiu, Andrew G. Watts, Luke L. Lairson, Nature Structural & Molecular Biology Bioorganic ChemistryBiochemistryNatural SciencesBiocatalysisEnzyme Catalysis	2004	219
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma Jaroslav Žák, Isaraphorn Pratumchai, Brett S. Marro, Science Lymphoid NeoplasiaHodgkin LymphomaCancer ImmunosurveillanceCheckpoint Inhibitor ImmunotherapyMedicine	2024	128
An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation Heiko Wurdak, Shoutian Zhu, Angélica Romero, Cell stem cell Developmental BiologyCell RegulationMedicineTumor SuppressorGene Expression	2010	126

Page 1